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Physiologically  relevant  in  vitro  models  can  serve  as  biological  analytical  platforms  for  testing  novel
treatments  and  drug  delivery  systems.  We  describe  the ﬁrst  steps  in the  development  of a 3D  human
brain  tumour  co-culture  model  that  includes  the  interplay  between  normal  and  tumour  tissue  along  with
nutrient gradients,  cell-cell  and cell-matrix  interactions.  The  human  medulloblastoma  cell line UW228-3
and  human  foetal  brain  tissue  were  marked  with  two  supravital  ﬂuorescent  dyes  (CDCFDASE,  Celltrace
Violet)  and  cultured  together  in ultra-low  attachment  96-well  plates  to form  reproducible  single  co-
culture spheroids  (d = 600  m,  CV%  =  10%).  Spheroids  were  treated  with  model  cytotoxic  drug  etoposide
(0.3–100  M)  and  the  viability  of  normal  and  tumour  tissue  quantiﬁed  separately  using  ﬂow  cytometry
and  multiphoton  microscopy.  Etoposide  levels  of  10 M were  found  to  maximise  toxicity  to  tumours  (6.5%o-culture spheroid
uman stem cell neurosphere
edulloblastoma
viability)  while  stem  cells  maintained  a surviving  fraction  of  40%.  The  ﬂexible  cell  marking  procedure
and  high-throughput  compatible  protocol  make  this  platform  highly  transferable  to other  cell  types,
primary  tissues  and  personalised  screening  programs.  The  model’s  key  anticipated  use  is for  screening
and  assessment  of drug  delivery  strategies  to  target  brain  tumours,  and  is  ready  for  further  developments,
e.g.  differentiation  of  stem  cells  to a range  of  cell types  and  more  extensive  biological  validation.
© 2015  The  Authors.  Published  by  Elsevier  B.V.  This  is  an open  access  article  under  the  CC  BY  license. Introduction
Advancements in the treatment of cancer depend on physiolog-
cally relevant in vitro models to detect and prioritise novel drugs
nd drug delivery strategies. The use of reductionist monolayer
ultures with non-physiological levels of oxygen (Carrera et al.,
010), combined with lack of cell–cell and cell–matrix interactions
Cukierman et al., 2001), often produce answers that are not repre-
entative of in vivo response. The likelihood of approval of emerging
ancer therapies is currently below 10% (Hay et al., 2014), which is
n part due to lack of reliable in vitro models (Astashkina et al.,
012).
∗ Corresponding author. Tel.: +44 0 115 84 68559.
E-mail addresses: paxdi@nottingham.ac.uk (D.P. Ivanov),
erry.parker@nottingham.ac.uk (T.L. Parker), david.walker@nottingham.ac.uk
D.A. Walker), cameron.alexander@nottingham.ac.uk (C. Alexander),
arianne.Ashford@astrazeneca.com (M.B. Ashford), Paul.Gellert@astrazeneca.com
P.R. Gellert), m.garnett@nottingham.ac.uk (M.C. Garnett).
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Brain tumours are especially difﬁcult to treat because of the
challenges posed by the blood-brain barrier (Muldoon et al., 2007).
The BBB limits the transport of many chemotherapy drugs and
especially those which are hydrophilic, highly protein-bound or
with molecular weight over 400 Da (Shen et al., 2004). Possible
strategies to overcome the BBB are barrier disruption, blocking of
efﬂux pumps, utilising transporters and local drug delivery (Deeken
and Löscher, 2007). Local delivery to the brain can be achieved
using convection enhanced systems (Barua et al., 2013), postsurgi-
cal delivery systems like Gliadel (Attenello et al., 2008), mouldable
matrices (Rahman et al., 2013), or by infusion of drugs into the
cerebrospinal ﬂuid (Conroy et al., 2010).
In vitro modelling of local drug delivery to brain tumours can
add in the rational design of drug delivery systems. Employing
cultures of both normal and tumour tissue provides informa-
tion for the relative safety and efﬁcacy of treatment and can be
used to rank formulations according to their therapeutic safety
ratio (Hickman, 2014). Our previous studies (Meng et al., 2007)
have indicated that using the correct dimensionality plays a sig-
niﬁcant role in modelling the physiological response of in vitro
nder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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ultures. Fluorescently-labelled biodegradable nanoparticles were
aken up six times more in tumour spheroids made of DAOY
edulloblastoma cells compared to normal tissue (rat brain slices)
hen cultured together in 3D (Meng, 2006). These effects were
nly observed in three-dimensional cultures where the biolog-
cally appropriate cell interactions and physiological gradients
ere present. In order to increase the biorelevance of this model
o humans and eliminate the pitfalls of interspecies differences
Rangarajan et al., 2004) we decided to pursue an improved ver-
ion of the in vitro system employing only human tissues, cultured
n scaffold-free spheroid cultures.
In our most recent in vitro model (Ivanov et al., 2014), medul-
oblastoma and stem cell spheroids were cultured in separate
ells and analysed with a battery of multiplexable assays. How-
ver culturing both cell types separately did not allow for any
nteraction between the tumour cells and the normal tissue. The
irect and paracrine tumour–host interaction has been repeat-
dly demonstrated to affect chemo (Straussman et al., 2012) and
adiosensitivity (Upreti et al., 2011), proliferation (Spink et al.,
006), angiogenesis (Wartenberg, 2001), cell adhesion (Chambers
t al., 2011) and gene expression (L Berg et al., 2014). Spheroid
o-cultures have been used to demonstrate differential response
o local intravesical treatment in bladder cancer (Kilani et al., 2003,
002). Moreover, including a normal tissue component was proven
o be vital in the successful development of lung cancer models
Amann et al., 2014). Therefore we have chosen to include the
ormal brain tissue in a co-culture with the tumours to provide
 surrogate for tumour-host interactions and serve as an internal
ontrol for treatment toxicity.
There are a number of methods that can be used to distin-
uish between different populations of cells cultured together in
o-cultures. Speciﬁc antigens can be employed (Kilani et al., 2003;
han-Lai et al., 2013), cells can be genetically modiﬁed to express
uorescent proteins (Fang et al., 2013; Hsiao et al., 2009) and ﬂuo-
escent dyes can be utilised for medium-term cell monitoring (Go
t al., 1997).
Medulloblastoma is an embryonal tumour that shares many
ntigens with developing neural progenitor cells (Carpenter et al.,
999; Nagato et al., 2005; Srivastava and Nalbantoglu, 2008;
anner et al., 2014; Zanini et al., 2013). The common antigen pre-
entation precludes the use of speciﬁc antibodies to distinguish
etween developing brain tissue and the tumour cells. Moreover,
edulloblastoma is made up of least four clinically and molecularly
istinct types of tumours (Taylor et al., 2012). There appear to be
urther differences within subgroups (Kool et al., 2014; Shih et al.,
014) as well as intratumoral heterogeneity especially after treat-
ent with radiation and chemotherapy (Ramaswamy et al., 2013).
n this respect using genetic manipulation to mark the cells would
ead to single clone selection and limit the usefulness of the system
y eliminating heterogeneity. Therefore, marking with ﬂuorescent
upravital dyes was chosen as the best method for cell track-
ng because of its ﬂexibility, no requirement for speciﬁc antigens,
nd compatibility with primary tissue due to tissue heterogeneity
reservation.
We have employed a suite of imaging and analytical tech-
iques to characterise the co-cultures and quantify the number
nd health status of the labelled cells. Microscopy-based anal-
sis offers the opportunity to image the intact spheroids and
eveal the spatial distribution and interaction between both cell
ypes. However, confocal microscopy is limited by the penetration
epth of short wavelength photons and can cause considerable
issue photobleaching. In contrast, multiphoton microscopy uses
onger wavelength photons which can penetrate deeper into the
pheroids. Both microscopy techniques are limited in the num-
er of ﬂuorophores they can analyse and spectral overlap can be
 signiﬁcant problem.chnology 205 (2015) 3–13
Flow cytometry circumvents the abovementioned obstacles by
illuminating the cells with light from different lasers and detecting
the emitted ﬂuorescence in a number of separate channels. While
ﬂow cytometry does not reveal the 3-D organisation within the co-
culture, it has a larger dynamic range than ﬂuorescence microscopy
and is less susceptible to ﬂuorescence interference. It also allows
the use of more colours and provides superior data handling tools
compared to the analysis of multiphoton images. Hence it was the
preferred mode for stem cell and tumour population quantiﬁcation
and determination of cellular health status.
Here we report a proof of concept study in the technical
development of a co-culture in vitro model of human medulloblas-
toma to use as an assessment tool for drug delivery. The model
utilises the UW228-3 cell line and human foetal brain tissue cul-
tured as neurospheres in deﬁned serum-free stem cell media. The
medulloblastoma cell line was  chosen to mimic small foci of left-
over tumour tissue after surgery and leptomeningeal metastases.
These cells were cultured together with foetal human brain tissue
enriched for progenitor cells to represent, in model form, a devel-
oping child’s brain. Etoposide was used as a clinically-important
cytotoxic drug to test the safety and efﬁcacy of local chemotherapy
aimed at brain tumours.
2. Materials and methods
2.1. Materials
Dulbecco’s Phosphate Buffered Saline (PBS), Dulbecco’s Mod-
iﬁed Eagle’s Medium - high glucose (DMEM), Ham’s nutrient
mixture F12, L-Glutamine, Heparin, Sodium pyruvate and etopo-
side were obtained from Sigma–Aldrich (Dorset, UK).
Foetal Bovine Serum (FBS), N2 supplement, B27 serum-free
supplement, DMEM without phenol red, basic human Fibroblast
Growth Factor (bFGF), human recombinant Epidermal Growth
Factor (EGF), Accutase, CellTrace Violet and 5-(and-6)-carboxy-
2′,7′-dichloroﬂuorescein diacetate succinimidyl ester (CDCFDASE)
were supplied by Invitrogen (Paisley, UK).
Annexin V-Allophycocyanin (Annexin-APC, 20X solution) and
7-Aminoactinomycin D (7-AAD, 50 g/ml) were purchased from
Ebioscience (Hatﬁeld, UK).
Ultra low attachment (ULA) 96-well round bottom plates were
obtained from Corning (Amsterdam, The Netherlands)
2.2. Cell lines and culture
All experiments were performed in standard cell culture condi-
tions at 37 ◦C and 5% CO2.
UW228-3 medulloblastoma cell line (Keles et al., 1995) was
obtained from Prof. Silber (University of Washington, Seattle, USA)
with the help of the Children’s Brain Tumour Research Centre at the
University of Nottingham. UW cells were cultured in DMEM/F12
media supplemented with l-Glutamine (2 mM),  sodium pyruvate
(1 mM)  and FCS (10%). Subculturing was performed using 0.025%
Trypsin in Ca2+ and Mg2+ free PBS solution for 5 minutes.
Foetal human brain tissue was  received from the Joint
MRC/Wellcome Trust (grant # 099175/Z/12/Z, Ethics commit-
tee approval 08/H0906/21 + 5, Health Research authority NRES
Committee North East - Newcastle & North Tyneside 1) Human
Developmental Biology Resource (www.hdbr.org). The tissue was
rinsed, mechanically dissociated into a single cell suspension and
cultured in non-treated ﬂasks to form stem cell enriched neuro-
spheres (Uchida et al., 2000).
The Neural stem cell (NSC) deﬁned serum-free media was
made using DMEM/F12 (1:1), B27 (1:50), N2 (1:100), l-Glutamine
(2 mM),  hEGF (20 ng/ml), bFGF (10 ng/ml) and Heparin (5 g/ml).
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Table 1
Dye combination and detection conﬁguration used in the Flowsight imaging ﬂow
cytometer.
Dye Function Excitation Emission
CellTrace Violet Cell label (UW228-3) 405 Channel 7 (430–505)
CDCFDASE Cell label (NSC) 488 Channel 2 (505–560)D.P. Ivanov et al. / Journal o
eurospheres were subcultured for less than 15 passages. Brieﬂy,
hen the neurospheres reached a diameter of 100–300 m they
ere rinsed with PBS, resuspended in Accutase (1 ml)  and agi-
ated for 5 min  at 37 ◦C followed by mechanical dissociation. The
uspension was diluted with fresh NSC media and centrifuged at
00 g for 5 min. The cell pellet was resuspended in Ca2+ and Mg2+
ree PBS and the ﬁnal single-cell suspension diluted to the desired
oncentration with NSC media.
.3. Cell label optimisation experiments
Cell marking optimisation screening was performed with UW
nd NSC cells with both CellTrace Violet and CDCFDASE in concen-
rations ranging from 2.5 to 20 M.
UW228-3 (UW) cells were labelled in monolayers prior to cul-
uring as spheroids. Cells, grown to 80% conﬂuence in cell culture
reated ﬂasks, were washed twice with HBSS (with Ca2+ and Mg2+)
nd incubated with 2.5–20 M concentrations of CDCFDASE and
ellTrace Violet in HBSS (with Ca2+ and Mg2+) for 30 min  at 37 ◦C.
fterwards they were washed twice with HBSS and incubated for
urther 3–4 h in FCM in order to remove any unconjugated dye. The
abelled cells were dissociated using 0.025% Trypsin
Neural stem cell (NSC) spheroids were dissociated and the cell
uspension was incubated with 2.5–20 M concentrations of CDCF-
ASE and CellTrace in HBSS for 30 min  at 37 ◦C.
Both cell types were seeded in ultra-low attachment plates
200 l, 7000 cells per well). The plates were centrifuged lightly
t 100 g for 3 min  after seeding and the cells organised into one
ingle spheroid per well within 24 h. Controls of unstained cells of
ach type were included in every plate. Old media were carefully
xchanged with fresh media (150 l) on days 3 and 5. Spheroids
ere cultured for 7 days before ﬁnal analysis.
The effect of both cell marker dyes on spheroid proliferation and
etabolic activity were assessed by comparing marked spheroid
olume and metabolic activity to unstained controls. Flow cytom-
try was used to assess dye retention in each condition.
.4. Co-culture formation
Co-culture spheroids were established by plating a homogenous
ix  of ﬂuorescently labelled tumour and stem cells (200 l, 3500
ells/well from each type) as a single-cell suspension in ULA plates
t the same time. Co-culture spheroids formed in 24 h and were
ultured for 7 days, exchanging with fresh media (150 l) on days
 and 5.
.5. Spheroid viability monitoring
Spheroid growth was monitored using an Olympus CKX41
icroscope with a 10X objective and an attached Olympus E330
amera. The scale of images was determined using a calibration
lide. Images were analysed using a specially written macro (Ivanov
t al., 2014) for the open-source software ImageJ (Fiji 2013 package)
nd spheroid area was used to calculate the volume of an equivalent
phere as a proxy for growth and viability.
Spheroid metabolic activity was determined using Resazurin
eduction. On day 7 the old media in each well were exchanged for
resh media (150 l) supplemented with Resazurin (60 M)  from
 freshly-thawed stock solution (440 M).  Spheroids were placed
or 4 h in the incubator and ﬂuorescence was measured with an
xcitation wavelength of 530 nm and emission 590 nm on a Galaxy
luostar plate reader..6. Multiphoton confocal microscopy
Spheroids were ﬁxed using polyformaldehyde solution (4%)
fter washing twice with PBS (150 l). The spheroids were stored7-AAD Dead and apoptotic cells 488 Channel 5 (642–740)
Annexin-V Early apoptotic cells 642 Channel 11 (642–740)
in the plates at 4 ◦C in PBS protected from light. Imaging was done
by placing the spheroids on top of a glass slide along with 20 l
of PBS. Zeiss LSM510NLO confocal multiphoton microscope was
used with a Plan-apochromat 20x/0.8 objective and 800 nm exci-
tation wavelength. Images were later processed using ImageJ by
auto-adjustment of brightness and contrast, followed by creating
an average intensity Z-projection.
2.7. Cytotoxicity screen
Labelled spheroid co-cultures were seeded in ULA plates and
exposed to increasing concentrations (0.3–100 M) etoposide on
day 3. Etoposide was replaced with fresh media on day 5 and ana-
lysed on day 7. Controls included in the screen were unstained
single cultures of UW and NSC cells, unstained co-culture, single
colour controls and labelled co-culture control with media and
DMSO (0.2%). Six spheroids per condition were analysed on each
plate. Brightﬁeld images of the cultures were used to determine
the volume of the spheroids compared to untreated controls. The
percentage of each population was  estimated using ﬂow cytometry.
2.8. Flow-cytometry
Spheroids were washed twice with PBS (150 l/well), dissoci-
ated using Accutase (double concentrated, 50 l/well) for 30 min
at 37 ◦C followed by mechanical dissociation by repeated pipetting.
The resultant single cell suspensions from six wells per condition
were pooled together in a microcentrifuge tube, centrifuged (300 g,
5 min) and resuspended in Annexin binding buffer (10 mM HEPES,
140 mM NaCl, 2.5 mM CaCl2 pH = 7.4; 50 l). Dead and apoptotic
cells were stained using 7-AAD (5 l, 50 g/ml) as per (Zembruski
et al., 2012). Early apoptotic cells were detected using Annexin
V-APC (2.5 l). After incubation for 15 min  in the dark, further
Annexin binding buffer (200 l) was  added and the cells stored on
ice, protected from light were analysed within 2 h. Flow cytometry
experiments were done using a 14 channel MoFlo XDP cell sorter
(Beckman Coulter) equipped with a three laser system (405, 488
and 630 nm). CDCFDASE and 7-AAD positive cells were detected
using the blue 488 nm laser and the 529/28 and 670/30 channels
respectively. CellTrace Violet positive cells were excited with the
violet 405 nm laser and detected with a 450/65 ﬁlter. The Annexin
V-APC positive apoptotic cells were excited by the red 630 nm laser
and detected in the 670/30 channel. Non-stained and single colour
controls were included in each experiment. Data were analysed
using the Weasel software package. Debris were identiﬁed and
subsequently excluded by gating the Annexin V-APC and 7-AAD
negative population on the Forward/side scatter dot plot and select-
ing for the particles with the lowest forward scatter values (Duggan,
2012).
2.9. Imaging ﬂow cytometryImaging ﬂow cytometry using the Amnis Flowsight system
was used to visualise the dissociated cells from the spheroid
co-cultures. The following combination of lasers and detectors
was employed (Table 1). Non-stained and single colour controls
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Table 2
Marking UW-228 and NSC cells with supravital dyes CDCFDASE and CellTrace Violet.
Percentage of positive cells is given compared to unstained control.
Condition % Positive cells
UW228-3 NSC
Control 2 2
CellTrace 2.5 M 63 74
CellTrace 5 M 71 94
CellTrace 10 M 90 99
CellTrace 20 M 96 100
CDCFDASE 2.5 M – 50
CDCFDASE 5 M 77 93
CDCFDASE 10 M 86 98
F
m D.P. Ivanov et al. / Journal o
ere used to calibrate the channels and data were analysed on the
MNIS IDEAS Software.
.10. Data analysis and statistical analysis
Raw data from volume determination, Resazurin reduction, and
ow cytometry software were exported and analysed in MS  Excel
nd Graphpad Prism 6. In label optimisation experiments, read-
ngs were normalised to the relevant unstained control (100%) and
pheroid-free wells (0%). In cytotoxicity experiments, volume mea-
urements were normalized so that untreated co-culture controls
ere assigned to 100% viability and media-only wells- 0% viability.
low cytometry results for the proportion of stem cells and tumours
ere multiplied by the volume of each spheroid to estimate the sur-
iving fraction of each cell type. Dose response curves were ﬁtted
sing the four-parameter logistic equation in Prism, the top was
onstrained to 100% and the bottom to 5%. Results are displayed as
ean ± SD unless stated otherwise. There were n = 6 replicates for
ach condition in each individual experiment and displayed data
epresent the mean of at least three independent experiments.
. Results
.1. Cell marking optimisation
The ﬁrst task in establishing the co-culture models was  to make
ure that both cell types (UW and NSC cells) could be reliably dis-
inguished from each other. A dye optimisation experiment was
erformed in order to investigate which marking strategy would
e most suitable for marking for each of the two  cell populations.
t aimed to establish the most favourable concentration to label
he cells speciﬁcally without pronounced toxic effects. UW228-3
nd NSC cells were marked with CDCFDASE and CellTrace Violet in
oncentrations ranging from 2.5 to 20 M.  Fig. 1 shows the impact
f dye concentration on the frequency distribution of cellular ﬂu-
rescence in the ﬂuorescent channels of CDCFDASE and CellTrace
iolet. Despite the low mean ﬂuorescence of non-marked UW cells,
ye concentrations lower than 10 M did not shift the population’s
uorescence distribution at day 7 far enough to achieve a good
ig. 1. Histograms of the frequency distributions of long-term ﬂuorescent labelling for U
arked  with CellTrace Violet, B-UW cells marked with CDCFDASE, C-NSC cells marked wCDCFDASE 20 M 85 99
separation from the control. As seen in Fig. 1A and B the optimal
staining concentration for the tumours was  10 M for both dyes
and little was gained from increasing dye levels to 20 M.  The stem
cell population on the other hand showed a very pronounced differ-
ence in the distribution of the ﬂuorescence signal with increasing
dye concentrations. Fig. 1C illustrates the gradual shift of the ﬂu-
orescence for the whole stem cell population and clearly shows
that CellTrace Violet can effectively mark the cells at levels as low
as 5 M.  CDCFDASE followed a similar trend in Fig. 1D although
the shift was  less pronounced when compared to CellTrace Vio-
let. Overall, in the conditions tested, CellTrace Violet was superior
in marking the cells compared to CDCFDASE because it elicited a
more pronounced shift in the ﬂuorescence of both cell types.
These results were conﬁrmed when the relative percentages
of cells with ﬂuorescence brighter than control were compared in
Table 2. The data demonstrates that levels of 10 M were needed to
stain tumour cells and 5 M were sufﬁcient for stem cells for both
dyes. Although these data indicated a combination of 10 M Cell-
Trace Violet for the UW and 5 M CDCFDASE for the NSC might be
advantageous, the superiority of this combination became visually
apparent after comparing the dot plots in Fig. 2.Fig. 2 shows the rationale behind choosing the appropriate dye
for the stem cells and tumours. Complete and effective resolution
of the two  populations is only achieved by using CDCFDASE for
W and NSC cells labelled with CellTrace Violet and CDCFDASE (Green). A- UW  cells
ith CellTraceViolet, D-NSC marked with CDCFDASE.
D.P. Ivanov et al. / Journal of Biotechnology 205 (2015) 3–13 7
Fig. 2. Two  dimensional dot plots showing single and mixed populations of UW and NSC cells marked with both dyes. X-axis shows intensity of ﬂuorescence in the CDCFDASE
channel, Y-axis ﬂuorescence intensity in the CellTrace Violet channel. Quadrants are deﬁned by the autoﬂuorescence intensity values for the unstained stem cell population
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chich  are within the lower left quadrant of the plots A- UW marked with 10 M C
SC-CDCFDASE, D-NSC marked with 5 M CellTrace Violet, E- UW marked with 10
he foetal tissue and CellTrace Violet for the tumours (Fig. 2C).
his cell discrimination can be explained with the higher auto-
uorescence of stem cells compared to tumours. CellTrace Violet
chieves a more pronounced shift in ﬂuorescence for the tumours
hich, combined with their intrinsically low autoﬂuorescence in
he CDCFDASE channel, leads to better separation from the stem
ell population. In contrast the small shift in UW cell ﬂuores-
ence achieved by CDCFDASE is sufﬁcient to distinguish them from
nstained tumour cells but not enough to differentiate them from
he stem cells (Fig. 2F).
In order to investigate the effect of marking the cells with
uorescent dyes on spheroid viability and growth, the volume
nd metabolic activity of stained spheroids were compared to
nstained spheroids of UW and NSC cells. Fig. 3A shows that stem
ells treated with increasing concentrations of each dye yielded
maller spheroids after 7 days of culture compared to untreated
ontrols. This effect was less pronounced for UW spheroids which
ere only affected at concentrations above 10 M.  Nevertheless,
etabolic activity (Fig. 3B) for all spheroids, as determined by
ig. 3. Volume and metabolic activity of spheroids marked with the supravital dyes co
ifferent levels of ﬂuorescent dyes after 7 days of culture compared to unstained contr
ompared to control. C- Volume of stem cell and tumour spheroids stained with 5 M CDe Violet, B- NSC marked with 5 M CDCFDASE, C- mix  of UW-CellTrace Violet and
DCFDASE, F- mix  of UW-CDCFDASE and NSC-CellTrace Violet.
Resazurin reduction, was above 80% when dye concentration was
kept below 10 M.  Fig. 3C shows the volume of marked spheroids
made of UW of NSC cells marked with 10 M CellTrace Violet
and 5 M CDCFDASE respectively. The results of ﬁve independent
experiments showed that while stem cells produced 30% smaller
spheroids than unstained controls, tumours were less affected by
the dying procedure and only had 10% lower volume compared to
controls.
3.2. Effects of etoposide treatment
After the initial optimisation experiments the marked tumour
and stem cells were seeded and cultured together in co-culture
mimicking the interaction between normal brain and tumour tis-
sue (Fig. 4). These co-cultures were allowed to grow for 3 days
before they were exposed to etoposide for 48 h followed by another
2 days in etoposide-free media. The right panel in Fig. 4 shows light
microscopy images of the spheroids after 7 days of culture along
with the conditions in each column.
mpared to unstained controls A-Volume of UW and NSC spheroids marked with
ols. B- Metabolic activity of the same spheroids measured as resazurin reduction
CFDASE and 10 M CellTrace Violet respectively compared to unmarked controls.
8 D.P. Ivanov et al. / Journal of Biotechnology 205 (2015) 3–13
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tig. 4. Medulloblastoma in vitro model experimental setup. Left panel- co-culture fo
ontrast microscopy image after 7 days of culture along with conditions for each co
Fig. 5 shows the light and multiphoton microscope images of the
o-cultures and the ﬂowchart for ﬂow cytometry gating and anal-
sis. The multiphoton images reveal the spatial distribution of the
wo cell populations while ﬂow cytometry was used to quantify the
roportion of each cell type. Despite seeding the cells together in
he form of a mixed single cell suspension, the cells organised them-
elves into polarised spheroids with discrete tumour-dominated
nd stem cell-dominated regions. As seen in the images, there
ere tumour cells detectable within the stem cell part, resembling
etastases, and a fraction of double positive cells whose origin
ould not be identiﬁed solely on the basis of imaging. Flow cytom-
try after spheroid dissociation was used to quantitate the ratio
f tumour and stem cells within the mixed cultures and moni-
or the effects of etoposide. The stem cells were well segregated
rom the tumours due to the bright CDCFDASE staining. The double-
ositive cells, which were highly ﬂuorescent in both channels, were
learly separated from the tumour population and clustered with
he stem cells. Each population was further examined for apoptosis-
elated phosphatidylserine externalisation using Annexin V-APC
Koopman et al., 1994) and for 7-AAD uptake (Zembruski et al.,
012) to infer cell death.
Etoposide addition profoundly altered the ratio of tumours to
tem cells in the spheroids. As seen in Fig. 6, with increasing
ig. 5. Medulloblastoma co-culture model analysis. Top left- phase contrast microscopy 
ells  are NSC. Bottom left multiphoton average intensity z-stack projection image of co-c
ositive  cells. Scale bars 200 m.  After dissociation into single cells spheroids were analy
opulations can be gated separately owing to their different ﬂuorescence in both channe
ot  plots show tumour (top panel) and stem cells (bottom panel) assayed separately for v
hat  living cells have low 7-AAD ﬂuorescence, apoptotic medium and dead-high as descrion in overlay and etoposide exposure. Right panel- 96-well plate experiment phase
. Scale bar is 500 m.
etoposide concentration the tumour cell proportion dropped signif-
icantly and reached its lowest point at 10 M etoposide. Although
both populations started at similar numbers, increasing etopo-
side concentrations primarily targeted the tumours and at 10 M
the spheroids were composed predominantly of stem cells. This
is in agreement with the results from the two photon confocal
microscopy shown in the bottom panel. The average intensity z-
stacks show a progressive elimination of the tumour cells with
only traces of these cells left at the 10 M concentration. Neverthe-
less, the decrease in tumour burden was  not wholly advantageous
and higher etoposide concentrations elicited a shrinkage of the
spheroid as a whole, indicating toxicity to the stem cells as well.
Dose-response curves were extrapolated by using the volume of
the co-culture spheroids and the proportion of stem-cells to tumour
cells determined by ﬂow cytometry in order to fully describe the
effects of etoposide on both populations. The resultant values were
normalised to the initial values for stem cells and tumours respec-
tively and the results plotted in Fig. 7A. Despite the variability
between the different experiments there was a clear dose-response
trend in which stem cell viability was  lower or equal to that of
tumours below 3 M and higher at etoposide levels between 3 and
10 M.  The most favourable etoposide concentration 10 M when
the viability of NSC (41%) was 6 times higher than tumour viability
image of co-culture spheroid. Darker sphere is made up of UW cells while brighter
ulture spheroids. Green cells represent NSC, blue cells–UW228-3 and Cyan-double
sed using ﬂow cytometry. Middle dot plot panel shows that tumour and stem cell
ls. Double positive cells in middle dot plot appear to cluster with stem cells. Right
iability using Annexin-APC for apoptotic cells and 7-AAD to mark dead cells. Note
bed by Zembruski et al., 2012.
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Fig. 6. Co-cultures exposed to different levels of etoposide. Dot plots and multiphoton images. The top panel shows dot plots for the live cells in the spheroid. Top left plot
represents the living cells in the controls, cultured in media and DMSO. The dot plots are marked with the relevant etoposide concentration in M.  The proportional increase
of  stem cell to tumours shown in the dot plots is represented by the pie charts of the middle row. Increasing concentrations of etoposide gradually eliminated the tumours
cells.  Bottom row shows multiphoton microscope average intensity z-stacks of spheroids cultured at the above conditions. Blue cells are UW tumours, green cells are stem
cells  and scale bars are 200 m.
Fig. 7. Dose-response data for co-cultures of neural stem cells and UW medulloblastoma cells exposed to etoposide. A-Comparison of viability for each population calculated
from  the total volume of the co-culture spheroid (image analysis) and the ratio between stem cells and tumours (ﬂow cytometry). Error bars represent SEM for n = 4
i  10 M
v 0 for s
f
(
e
f
s
o
t
i
F
v
ondependent experiments B- comparison of the viability of stem cells and tumours at
ariability of the data for the stem cells and the narrow distribution for tumours. IC5
or  UW228-3 cells.
6.5%) as shown in Fig. 7B. This was a statistically signiﬁcant differ-
nce as determined by a two-tailed t-test with Welch’s correction
or unequal variance (p = 0.0257). The observed higher viability of
tem cells at 10 M etoposide is in agreement with the results from
ur previous study in separate cultures of unlabelled stem cell and
umour spheroids (Ivanov et al., 2014).
In addition to the conventional ﬂow cytometry experiments,
maging ﬂow cytometry was employed in order to visualise
ig. 8. Imaging ﬂow cytometry- representative examples of the different cell population
iolet  channel. Apoptotic cells show a membrane associated ﬂuorescence in the AnnexinV
n  double-positive cells register on both the green and the violet channels. etoposide, dots represent separate experiments. Note the high inter-experimental
tem cells was calculated to be 3 M (95%CI = 2–7 M) and 1 M (95% CI = 0.8–2 M)
and better characterise the separate populations (Fig. 8). The
stem cells gave a bright signal in the green channel whereas
the tumours were positive for CellTrace Violet ﬂuorescence. The
membrane distribution of phosphatidylserine in apoptotic cells
was also visualised. In addition the double positive cells were
conﬁrmed to be stem cells that had small particles attached
to them responsible for the high-ﬂuorescence in the violet
channel.
s. Stem cells are positive in the green channel, while tumours are registered in the
-APC channel with in agreement with externalisation of phosphatidylserine. Blebs
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. Discussion
The most common strategies for long-term supravital ﬂuo-
escent cell marking involve either marking the cell membrane
ith lipophilic carbocyanine dyes (Honig and Hume, 1986), or
referential cytosolic protein marking with amine-reactive com-
ounds (Weston and Parish, 1990). Nuclear staining dyes like
oechst 33342 were not considered because of their reported DNA
nteraction and short-lived labelling (Samlowski et al., 1991). The
hiol-reactive CellTracker Violet (BMQC) appeared to be toxic to
he cell lines tested (data not shown) and was excluded as well.
espite the proven track record of carbocyanine dyes in neuron
abelling their ﬂuorescence staining can often diminish before anal-
sis (Chintala et al., 1997) and dye transfer to the nearby cells
as been reported (Khoshyomn et al., 1998; Lassailly et al., 2010;
ygaard et al., 1998).
The amine-reactive dyes have been reported to be superior in
eak resolution and non-speciﬁc dye transfer compared to the
embrane-staining dyes (Begum et al., 2013) CDCFDASE is the
,7-dichloro derivative of CFDA SE (Parish, 1999) which is less sus-
eptible to photobleaching and pH ﬂuctuations. Both CDCFDASE
nd CellTrace Violet share the same mechanism for marking the
ells- acetate groups allow the molecules to cross the cell mem-
rane and are subsequently cleaved in the cytoplasm. Afterwards
he succinimidyl moiety reacts with amino groups of cytosolic pro-
eins and labels the cells for about 5–8 cell divisions (Quah and
arish, 2012). This staining strategy can be used on any cell type and
s substantially less toxic compared to chloro- and bromo-methyl
eactive dyes that bind to cellular glutathione.
We  were able to utilise both CDCFDASE and CellTrace Vio-
et in our co-culture model and maintain a high level of cellular
uorescence for 7 days. CellTrace Violet yielded a bigger shift
n ﬂuorescence compared to CDCFDASE and did not affect the
edulloblastoma spheroid volume or metabolic activity. Although
he ﬁnal stem cell neurosphere volume was 30% lower than the
nstained controls, the decreased sphere volume did not translate
o reduced metabolic activity up to levels of 10 M of CDCFDASE
nd CellTrace Violet.
Spheroid co-cultures have been extensively used for invasion
xperiments in glioblastoma (Chintala et al., 1997; Go et al., 1997;
erzis et al., 1997a, 1997b; Thorsen et al., 1997). These studies have
ighlighted the importance of having a normal tissue component
s well as the tumour cells. However these experiments relied on
echniques like agar overlay which produced spheroids of vary-
ng, poorly reproducible sizes which necessitated manual sorting
nd decreased throughput. In most of these studies the tumour
pheroids were exposed to the drug alone and only afterwards co-
ultured with the normal tissue. In contrast to other reports, which
ave employed a single cell label (Amann et al., 2014), marking
oth cell populations increased the ﬁdelity of cell type determina-
ion. Similarly, employing cytoplasmic dyes instead of membrane
arkers (Nygaard et al., 1998, 1995) resulted in stable marking for
ver 7 days with decreased dye loss or exchange between the two
opulations. Although other researchers have demonstrated the
easibility of differential cytotoxicity determination in co-culture
pheroids (Kilani et al., 2003, 2002), their cell labelling strategy was
nly possible for cells with differential antigen expression and was
ot suited for heterogeneous cell populations. Therefore we  have
olved a number of practical challenges associated with the pro-
uction of reproducible co-culture spheroids in a high-throughput
ompatible format and offer an improved labelling procedure well-
uited for heterogeneous primary tissue.A key technical problem with 3-D image analysis, is that
onfocal microscopy can only achieve 50–100 m penetration
n tissues (Indovina et al., 2007). We  have attempted to tackle
his problem by using two-photon microscopy. The multiphotonchnology 205 (2015) 3–13
microscopy technique employed in this study allows the imaging
of intact spheroids by using longer wavelength photons compared
to conventional confocal microscopy. These lower-energy pho-
tons penetrate deeper into the spheroids and reveal the intrinsic
3D distribution of each cell type within the spheroid. Moreover
multiphoton microscopy is more benign to tissue by limiting out-
of-focus phototoxicity and photobleaching (König et al., 2011).
Strikingly, although the tumours and stem cells were seeded
as a mix, they organised themselves into two poles- one enriched
for tumour and one for normal tissue. Additionally, as seen in
Figs. 5 and 6 there were a number of tumour foci within the nor-
mal  tissue mimicking tumour invasion into the brain parenchyma.
Spontaneous organisation of spheroids has been reported before
(Urich et al., 2013) and is probably driven in this case by cell-cell
recognition mechanisms. This is in agreement with the differential
adhesion hypothesis postulated by Steinberg where spontaneous
tissue segregation and sorting is thought to be guided by dif-
ferential expression of cadherins, causing differences in surface
tension between cell types (Foty and Steinberg, 2005). In previ-
ous work (Meng et al., 2007) we have seen invasion of DAOY
medulloblastoma spheroids into organotypic cultures of rat neona-
tal cerebellum compared to cortical slices, which are not invaded
signiﬁcantly by DAOY spheroids suggesting that the cues for this
cell behaviour can be very speciﬁc. Such interactions are reminis-
cent of the ‘seeds and soils’ hypothesis regarding the recognition
between cancer and normal cells and the spread of metastasis to
speciﬁc parts of the body (Langley and Fidler, 2011). The segre-
gation behaviour exhibited in our model in vitro is in agreement
with the growth and metastasis of tumour in vivo. Medulloblastoma
presents initially as a single tumour mass in the posterior fossa sep-
arate from the cerebellum and when it metastasizes it colonises the
craniospinal axis in small clumps (foci).
The combination of two  dyes made it possible to assess the
proportion of each cell population within the spheroid using ﬂow
cytometry after spheroid dissociation into single cells. The quan-
titative analysis of multiphoton images revealed the presence of
double positive cells whose identity was investigated by conven-
tional and imaging ﬂow cytometry. The double positive cells visible
in Figs. 5 and 6 clustered with the stem cell population in conven-
tional ﬂow cytometry dot plots. Moreover the image-based ﬂow
cytometer visualised those cells as stem cells with uniform green
ﬂuorescence and small particles with bright violet/blue ﬂuores-
cence attached to the outside of the cells (Fig. 8). With increasing
etoposide concentration the main tumour mass was  almost com-
pletely eliminated but some small groups of tumour cells remained
within the core of the spheroid.
The 3D co-culture model described here is made by simply
mixing the NSC and UW cells in a high-throughput compatible 96-
well format. No manual sorting, spheroid transfers or mixing are
required and all steps could potentially be automated to increase
productivity. The 96-well format allows the screening of a large
number of formulations and the elucidation of dose-response rela-
tionships. Furthermore we have included human foetal brain tissue
to understand better the off-target effects of local chemotherapy
on the developing brain and put the inhibitory drug concentra-
tions into clinical perspective. By harnessing these advantages we
were able to pinpoint a therapeutic range for etoposide between
3 and 10 M which maximises toxicity to tumours while stem cell
viability remains 6 times higher. These values are in agreement
with studies showing etoposide toxicity in the micromolar range in
medulloblastoma (Nör et al., 2013; Othman et al., 2014; Tomlinson
et al., 1991; Von Bueren et al., 2011) and a tenfold increase in
resistance for spheroids (Luo et al., 1998). This concentration of
etoposide can be achieved in patients by employing local intrathe-
cal therapy (Fleischhack et al., 2001; Slavc et al., 2003). Using IC50
values for tumour cell lines in isolation is of little value because
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hey do not translate directly to in vivo response. Relative toxicity
o normal and tumour tissue in the same compartment of the body
an better inform on potential side effects and therapeutic win-
ows. Therefore the inclusion of normal tissue not only increases
he biological relevance of the model by including tumour–host
nteractions but also gives a unique strength in that the normal cell
opulation serves as an internal control and “calibrates” the IC50
alues of the assay.
The toxicity to neural progenitors shown by the model has
lso been reported in mice (Nam et al., 2010). These ﬁndings are
n agreement with studies that have demonstrated the damaging
otential of cytotoxic drugs to progenitor cells in the subventricular
one (SVZ), dentate gyrus (DG) and the corpus callosum (Dietrich
t al., 2006). It should be noted, however, that the neurodevelop-
ental toxicity effects demonstrated by this in vitro model would
nly be replicated in patients if etoposide were to diffuse into
he SVZ and DG at high enough levels. Leptomeningeal tumour
etastases are in direct contact with the CSF and will receive the
ighest exposure to etoposide. In contrast progenitor cells in the
VZ are located tens of micrometres away from the wall of the
ateral ventricle behind a layer of ependymal cells and a hypocellu-
ar layer (Barbaro et al., 2004; Quin˜ones-Hinojosa and Chaichana,
007). Neurotoxic side effects in patients have been reported for
ther cytotoxics like cisplatin (Gregg et al., 1992), methotrex-
te (Bhojwani et al., 2014; Shuper et al., 2000) and cytarabine
Gállego Pérez-Larraya et al., 2011) but not for intrathecal etopo-
ide (Fleischhack et al., 2001; Slavc et al., 2003; Van der Gaast
t al., 1992) yet. Nevertheless, the ﬁndings in this study show that
toposide can damage proliferating cells regardless of their ori-
in and suggest that more targeted approaches like nanoparticle
ncapsulation (Meng et al., 2007) should be considered to improve
electivity. Drug delivery strategies that limit normal tissue expo-
ure and maximise the toxic effects to tumours are needed in order
o prevent off-target toxicity.
The UW228-3 cell line used in this study is reported to be sim-
lar to either Sonic hedgehog driven (SHH) (Pambid et al., 2014)
r Group 3 (Othman et al., 2014) medulloblastoma. Local intersti-
ial therapy at the tumour bed may  be most advantageous in SHH
edulloblastoma as it tends to recur mainly locally (Ramaswamy
t al., 2013). In contrast to that, the dismal prognosis and the fre-
uent leptomeningeal metastases associated with Group 3 may
avour the use of local intra-CSF delivery. Nevertheless, the chosen
ell line was used as a model serving to establish the methodology
f the assay and subsequent studies would include primary tumour
issue from patients.
The results from this study are supported by our previous work
here the stem cells and the UW228-3 cell line were cultured sep-
rately without previous labelling (Ivanov et al., 2014). Despite the
light differences in the calculated IC50s and the loss of resolution
o detect the biphasic NSC response, the general viability differ-
nces remained unchanged. In agreement with the single culture
tudies, stem cell viability was higher compared to tumours only
t levels around 10 M.
This study describes the initial proof of principle steps in
he technical development of a novel assay. There are a num-
er of future experiments that need to be performed in order
o better characterise the model in terms of biology and wider
ange of responses. A larger number of compounds needs to be
creened including neurotoxic anticancer drugs like vincristine,
ethotrexate and cisplatin as well as drugs without any reported
eurotoxicity. The assay would also proﬁt from the addition of
ider variety tumour cell lines that recapitulate all four types of
edulloblastoma.
Finally, the physiological relevance of this in vitro system might
e further improved by including an additional differentiation
nd maturation step in the culture of human neural stem cells.chnology 205 (2015) 3–13 11
Establishing the proportion of early progenitors, oligodendrocytes,
astrocytes and neurons in the model and determining the effects
of etoposide and other drugs on each population would further
beneﬁt our understanding of cytotoxic mode of action and neu-
rotoxic side effects. Thorough histological characterisation of both
the tumour and normal tissue components would also enrich the
model. The utilisation of patient-derived primary tumour tissue
would allow for a better representation of tumour heterogeneity
and holds potential in personalising therapy.
5. Conclusions
This 3D co-culture model includes biorelevant physiological
gradients of nutrients and oxygen, natural cell-cell and cell-matrix
interactions and the interplay between normal and tumour tis-
sue. It does so without sacriﬁcing throughput and the options
for complete automation. The unique combination of a universal
cell marking procedure along with ﬂow cytometry and multipho-
ton imaging make it possible to visualise the interaction between
tumour and host tissue and to quantify the effects of cytotoxic drugs
on both populations. This proof of concept study suggests a robust
method for co-culture creation and analysis that can be used in a
universal way to study interaction between any two  types of tissue
and drugs of interest.
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